Synapse - Works

Results (13087)

Efficacy of pirtobrutinib in BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Phase 1/2 BRUIN study results by prior BCL2-inhibitor therapy

Meeting Abstract

Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Pirtobrutinib in relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients with prior cBTKi: Updated safety and efficacy including high-risk subgroup analyses from the phase 1/2 BRUIN study

Meeting Abstract

Cohen, J. B.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Cheah, C. Y.; Eyre, T. A.; Ujjani, C. S.; Koh, Y.; Kim, W. S.; Nasta, S. D.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Pirtobrutinib in heavily pre-treated richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study

Meeting Abstract

Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffman, M. S.; Coombs, C. C.; Lamanna, N.; Shuo, M. A.; Jagadeesh, D.; Munir, T.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)

Meeting Abstract

Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas

Meeting Abstract

Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Prospective evaluation of a single-day multidisciplinary clinic for patients with locally advanced non-small cell lung cancer

Meeting Abstract

Billing, D. L.; Chaft, J. E.; Jones, D. R.; Daly, R.; Schoenfeld, A. J.; Mueller, B. A.; Preeshagul, I.; Park, B. J.; Iyengar, P.; Gomez, D. R.
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Clinical outcomes and immunotherapy retreatment in patients with metastatic NSCLC who complete at least two years of immune checkpoint blockade

Meeting Abstract

Ricciuti, B.; Hong, L.; Gariazzo, E.; Gorria, T.; Thummalapalli, R.; Awosika, N.; Mollica, L.; Citarella, F.; Gandhi, M.; Elkrief, A.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors

Meeting Abstract

Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Moyers, J. T.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Genomic correlates of response to chemoimmunotherapy in STK11MUT and KEAP1MUT metastatic non-small cell lung cancer

Meeting Abstract

Saini, A.; Elkrief, A.; Hong, L.; Ricciuti, B.; Garbo, E.; Pecci, F.; Makarem, M.; Di Federico, A.; Gandhi, M. M.; Aldea, M.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Machine learning-based clinicogenomic prediction of response to PD-(L)1 inhibition in KRAS altered non-small cell lung cancer

Meeting Abstract

Boiarsky, D.; Hong, L.; Ricciuti, B.; Cooper, A.; Saad, M.; Elkrief, A.; Di Federico, A.; Aminu, M.; Rinsurongkawong, W.; Lewis, J.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save